Filter Results:
(3,426)
Show Results For
- All HBS Web
(3,426)
- People (9)
- News (721)
- Research (2,192)
- Events (38)
- Multimedia (28)
- Faculty Publications (1,300)
Show Results For
- All HBS Web
(3,426)
- People (9)
- News (721)
- Research (2,192)
- Events (38)
- Multimedia (28)
- Faculty Publications (1,300)
- 2008
- Article
Entrepreneurial Ventures and Whole-body Donations: A Regional Perspective from the United States
By: Michel Anteby and Mikell Hyman
Human cadavers are crucial to medical science. While the debate on how to secure sufficient cadavers has focused primarily on donors' behaviors, procuring organizations' roles in increasing donations remain less explored. The United States offers a unique setting in... View Details
Keywords: Entrepreneurship; Behavior; Programs; Nonprofit Organizations; Business Ventures; Health Testing and Trials; Demand and Consumers; Supply Chain; For-Profit Firms; Organizations; Training; United States
Anteby, Michel, and Mikell Hyman. "Entrepreneurial Ventures and Whole-body Donations: A Regional Perspective from the United States." Social Science & Medicine 66, no. 4 (2008): 963–969.
- Portrait Project
Athena Ko
keep painting fences for inner city redevelopment. I will continue to believe though the sufferings around me severely test my faith. I will be honest when everyone feels they need to deceive. I will never let any pain, hardship, scorn or... View Details
- 01 Jun 2010
- News
The Art and Science of Teaching
techniques” is Lemov himself, according to a lengthy article on teaching in the New York Times Magazine in which Lemov was featured (March 7, 2010). And no one is more surprised than Lemov at his own success. Noting that a Myers-Briggs personality View Details
- 29 Dec 2019
- Research & Ideas
Read Our Most Popular Research Stories of 2019
buyouts on target firms and their workers vary greatly by deal type and market conditions. Experimentation and Startup Performance: Evidence from A/B Testing An analysis of the adoption of A/B testing... View Details
Keywords: by Sean Silverthorne
- February 2022 (Revised November 2022)
- Case
Nuritas
By: Mitchell Weiss, Satish Tadikonda, Vincent Dessain and Emer Moloney
Nora Khaldi had built a technology “to unlock the power of nature” in the service of extending human lifespan and improving health, and now in April 2020 was debating telling her Board of Directors she wanted to put on ice some of her discoveries. Nuritas, the company... View Details
Keywords: Cash Burn; Cash Flow Analysis; Pharmaceutical Companies; Founder; Artificial Intelligence; AI; Entrepreneurship; Health Testing and Trials; Health Care and Treatment; Decision Making; Market Entry and Exit; AI and Machine Learning; Pharmaceutical Industry
Weiss, Mitchell, Satish Tadikonda, Vincent Dessain, and Emer Moloney. "Nuritas." Harvard Business School Case 822-080, February 2022. (Revised November 2022.)
- Web
Frequently Asked Questions | MBA
Frequently Asked Questions MD / MBA If I am interested in pursuing the MD/MBA Program, when do I apply? When should I take the GMAT or GRE? Is one test preferred over the other? Is there a target test score?... View Details
- 01 Sep 2012
- News
Start It Up
which manufactures solar-paneled generators that require only minimal diesel to help recharge their batteries. In Iraq, “I’d see huge generators running all the time but powering very little,” Moorehead said. “We take it from running 24 hours down to 4 or 5 hours a... View Details
- Web
Success Academy Charter Schools | Information Technology
Development and Research test caption Previous test caption Previous Next test caption Previous Next More Featured Cases The Reinvention of Kodak Professor Ryan Raffaelli, Dave... View Details
- 01 Dec 2010
- News
Chaotic Funding Derails Research
"Of course it would be a different story entirely if we could extract crude oil from stem cells." © Jack Ziegler/The New Yorker Collection/www.cartoonbank.com In light of the latest developments of the on-again, off-again, on-again government funding of human embryonic... View Details
- 01 Mar 2016
- News
Off Script
(Thinkstock) Prescription drug spending increased by more than 13 percent in the United States in 2014, raising health insurance premiums and the ire of consumers and politicians. The reasons behind the rise are many, including the high cost of drug development—as much... View Details
- 22 Jan 2001
- Research & Ideas
Control Your Inventory in a World of Lean Retailing
manufacturer can increase profits and reduce inventory risks. To demonstrate that improvement, we ran a computer simulation that tests various inventory policies for three groups of SKUs in the same product line — one group with low... View Details
- 01 Jun 2024
- News
Decoding the Promise and Perils of Generative AI
opportunities, impact, and risks of GenAI. Several of these research efforts are highlighted below. Karim Lakhani Karim Lakhani Edward McFowland III Edward McFowland III How Will Generative AI Change Consulting? To test the capabilities... View Details
Keywords: April White
- 22 May 2020
- In Practice
Post-COVID Health Care: More Screens, Less Red Tape?
The coronavirus crisis forced health care providers to mobilize in ways few could have predicted six months ago, revealing not only the system’s weaknesses but its profound ingenuity. Within weeks, providers worldwide set up drive-through View Details
Keywords: by Danielle Kost
- Web
Application Process | MBA
will help us assess your qualifications. Remember, all materials must be submitted to HBS online by the application deadlines. The following serves as a preview of what you need to prepare. What You Need to Prepare Transcripts GRE / GMAT English Language View Details
- Web
Instant Photography Is Launched | Baker Library
Instant Photography Is Launched Edwin Land, positive test photograph (left) and negative test photograph (right), April 1946. Polaroid Corporation Records Related to Meroe Morse, b. VII.80, f. 5, f. 19.... View Details
- 01 Sep 2009
- News
Faculty Research Online
HBS Working Knowledge offers a first look at new thinking from HBS faculty. Read the complete articles summarized below by visiting their Web links. Sharpening Your Skills: Leading Change There’s nothing like a global recession to test... View Details
- 04 Apr 2018
- Op-Ed
Op-Ed: Why Private Investors Must Fund 'New Nuclear' Power Right Now
Drbouz In June 2016, I gave a TED Talk called We Need Nuclear Power to Solve Climate Change. The talk discussed the world’s realistic options for reducing fossil CO2 emissions soon enough to contain climate change’s more severe effects. To my surprise, that talk has... View Details
- 05 Jul 2006
- Research & Ideas
Reinventing the Dowdy Savings Bond
moderate-income families (LMI) families were given the option of redirecting some of their refund to savings? Would they take advantage? The Tax Test Tufano and a cross-sector team of nonprofit and private sector organizations explored... View Details
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
- February 2009
- Case
Avid Radiopharmaceuticals: The Venture Debt Question
By: Matthew Rhodes-Kropf and Ann Leamon
The CEO of a promising biotech company must decide how to respond to the macro-economic slump of late 2008. He had planned to pursue an aggressive schedule, moving the firm's Alzheimer's and Parkinson's disease imaging compounds through clinical trials and into the... View Details
Keywords: Financial Crisis; Entrepreneurship; Borrowing and Debt; Venture Capital; Financial Management; Investment; Health Testing and Trials; Expansion; Biotechnology Industry; Pharmaceutical Industry
Rhodes-Kropf, Matthew, and Ann Leamon. "Avid Radiopharmaceuticals: The Venture Debt Question." Harvard Business School Case 809-086, February 2009.